Caspofungin for the treatment of fungal infections: a systematic review of randomized controlled trials

Clinical Governance: An International Journal

ISSN: 1477-7274

Article publication date: 25 April 2008

63

Citation

(2008), "Caspofungin for the treatment of fungal infections: a systematic review of randomized controlled trials", Clinical Governance: An International Journal, Vol. 13 No. 2. https://doi.org/10.1108/cgij.2008.24813bae.011

Publisher

:

Emerald Group Publishing Limited

Copyright © 2008, Emerald Group Publishing Limited


Caspofungin for the treatment of fungal infections: a systematic review of randomized controlled trials

Article Type: Reviews of effectiveness From: Clinical Governance: An International Journal, Volume 13, Issue 2.

M.E. Falagas, F. Ntziora, G.I. Betsi and G. SamonisInternational Journal of Antimicrobial Agents2007Vol. 29pp. 136-43

This review evaluated the effectiveness and safety of caspofungin in the treatment of patients with fungal, mainly Candida, infections. The authors concluded that caspofungin is associated with a higher cure rate and fewer adverse effects in comparison with amphotericin B. These conclusions have to be viewed with caution since they are based on few studies with few participants.

Related articles